Alexander Kaltenborn

Alexander Kaltenborn

Auto-generated profile, based on publicly available information

Alexander Kaltenborn

Department of General, Visceral and Transplant Surgery, Hannover Medical School, Hannover, Germany

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AKAlexander Kaltenborn
Alexander Kaltenborn
CBCatherine M. Bourg
Catherine M. Bourg
AGAndreas Gutzeit
Andreas Gutzeit
FKFabian Kalberer
Fabian Kalberer
This study introduces and validates the Hip Lag Sign, a new clinical parameter to determine hip abductor damage, which appears to be one major cause for greater trochanteric pain syndrome. 26 patients who underwent standardized MRI-examination were prospectively enrolledbetween October 2009 and March 2012. A standard physical examination of the hip was performed, including the Hip Lag Sign as it is defined for the first time in this work. Hip Lag Sign results were statistically compared toMR images, to pain levels measured with the visual analogue scale and to results of the modified Harris Hip Score as a universal and well established diagnostic tool for the hip. Chi2- and Mann-Whitney-U-analysis were applied. Diagnostic accuracy was tested with 2×2-table-calculations.Kappa statistics were used to analyze inter-observer variability. A positive Hip Lag Sign is significantly associated with MRI-proven hip abductor damage (p<0.001). The Hip Lag Sign has a sensitivity of 89.47% and a specificity of 96.55%. The positive and negative predictive values are 94.44%, resp. 93.33%. Its diagnostic Odds Ratio is 239.000 (p<0.001; 95%-CI: 20.031-2827.819). The number needed to diagnose was 1.16.Inter-observer consistency was 98.1% and kappa statistics for inter-observer variability were 0.911. The Hip Lag Sign is specific and sensitive, easy and fast to perform and allows a reliable assessment on the hip abductors' status, especially when there is no access to further diagnostic devices such as MRI for example due to restricted resources like in developing countries. Thus, we recommend the inclusion of the Hip Lag Sign into everyday hip examinations, especially dealing with patients suffering from greater trochanteric pain syndrome.

1 January 2015 in Annals of Transplantation
Verified
Journal Article
Closed access
PDF file
HSHarald Schrem
Harald Schrem
AKAlexander Kaltenborn
Alexander Kaltenborn
CHCatharina Hartmann
Catharina Hartmann
RSRicardo Salinas
Ricardo Salinas
WRWolf Ramackers
Wolf Ramackers
JKJürgen Klempnauer
Jürgen Klempnauer
After introduction of MELD-based allocation in Germany, decreased waiting list mortality and increased mortality after transplantation have been reported.

24 December 2013 in Journal of Negative Results in BioMedicine
Verified
Journal Article
Open access
PDF file
BRBenedikt Reichert
Benedikt Reichert
AKAlexander Kaltenborn
Alexander Kaltenborn
AGAlon Goldis
Alon Goldis
HSHarald Schrem
Harald Schrem
Background: Liver transplantation is the only life-saving therapeutic option for end-stage liver disease. Progressive donor organ shortage and declining donor organ quality justify the evaluation of the leverage of the Donor-Risk-Index, which was recently adjusted to the Eurotransplant community’s requirements (ET-DRI). We analysed the prognostic value of the ET-DRI for the prediction of outcome after liver transplantation in our center within the Eurotransplant community. Results: 291 consecutive adult liver transplants were analysed in a single centre study with ongoing data collection. Determination of the area under the receiver operating characteristic curve (AUROC) was performed to calculate the sensitivity, specificity, and overall correctness of the Eurotransplant-Donor-Risk-Index (ET-DRI) for the prediction of 3-month and 1-year mortality, as well as 3-month and 1-year graft survival. Cut-off values were determined with the best Youden-index. The ET-DRI is unable to predict 3-month mortality (AUROC: 0.477) and 3-month graft survival (AUROC: 0.524) with acceptable sensitivity, specificity and overall correctness (54% and 56.3%, respectively). Logistic regression confirmed this finding (p = 0.573 and p = 0.163, respectively). Determined cut-off values of the ET-DRI for these predictions had no significant influence on long-term patient and graft survival (p = 0.230 and p = 0.083, respectively; Kaplan-Meier analysis with Log-Rank test). Conclusions: The ET-DRI should not be used for donor organ allocation policies without further evaluation, e.g. in combination with relevant recipient variables. Robust and objective prognostic scores for donor organ allocation purposes are desperately needed to balance equity and utility in donor organ allocation.

28 September 2014 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
AKAlexander Kaltenborn
Alexander Kaltenborn
JGJill Gwiasda
Jill Gwiasda
VAVolker Amelung
Volker Amelung
CKChristian Krauth
Christian Krauth
FLFrank Lehner
Frank Lehner
HSHarald Schrem
Harald Schrem
The question of whether the choice of preservation solution affects outcome after liver transplantation is still not satisfactorily answered. The purpose of this study is to examine the preservation solutions’ impact on outcome after liver transplantation. A double-center retrospective study of short- and long-term results of 3134 consecutive liver transplantations with follow-up periods up to 23 years was performed applying multivariate, risk-adjusted analyses with a subset for living-donor transplants, pediatric transplants and cases with prolonged cold ischemic times. An additional focus was put on biliary complications. The primary study endpoints were short- and long-term patient survival and death-censored graft survival. Secondary study endpoints were the occurrence of post-transplant complications, the necessity of operative revisions, the length of hospital stay, and the length of intensive care unit stay. Although long-term graft survival appears to be increased by Histidine-Tryptophan-Ketoglutarate-use (p = 0.018), this effect could not be confirmed in risk-adjusted analysis (p = 0.641). Multivariate regression analysis revealed that 3-month mortality (p = 0.120), 3-month graft survival (p = 0.103) and long-term patient survival (p = 0.235) were not influenced by the choice of preservation solution. There was no difference in the occurrence of common complications or necessity of operative revisions after liver transplantation. This was confirmed in subgroup analyses for living donor and pediatric transplantation and cases with prolonged cold ischemic time. Analysis of the preservation solutions’ impact on length of hospital (p = 0.113) and intensive care unit stay (p = 0.481) revealed no significant difference. University of Wisconsin and Histidine-Tryptophan-Ketoglutarate solutions are clinically equivalent. Histidine-Tryptophan-Ketoglutarate solution could have an economically superior profile. The notion that the choice of preservation solution can have an impact on the onset of biliary complications after liver transplantation remains a matter of controversy.

28 December 2015 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
AKAlexander Kaltenborn
Alexander Kaltenborn
SMSvenja Matzke
Svenja Matzke
MKMoritz Kleine
Moritz Kleine
TKTill Krech
Till Krech
WRWolf Ramackers
Wolf Ramackers
HSHarald Schrem
Harald Schrem

1 January 2015 in Annals of Transplantation
Verified
Journal Article
Closed access
PDF file
HSHarald Schrem
Harald Schrem
AKAlexander Kaltenborn
Alexander Kaltenborn
RSRicardo Salinas
Ricardo Salinas
MJMark D. Jäger
Mark D. Jäger
FLFrank Lehner
Frank Lehner
JKJürgen Klempnauer
Jürgen Klempnauer
BACKGROUND The model of end-stage liver disease (MELD) score is currently used for donor liver allocation in many regions. The objective of this retrospective study was to assess the MELD score and its diverse variants as prognostic models for mortality after liver transplantation. MATERIAL AND METHODS An analysis of 454 consecutive adult liver transplants since the introduction of MELD-based donor liver allocation was conducted. Eight different MELD score variants were investigated. Receiver operating characteristic (ROC) curve analysis was performed to calculate the sensitivity, specificity, and overall model correctness of the investigated scores as a predictive model. The Brier score was used for the prediction of model accuracy and calculated as described before. Study endpoints were 90-day mortality and long-term patient mortality. RESULTS A 90-day mortality of 15.4% (n=69) and long-term mortality of 25% (n=112) were observed. All investigated models fail to reach relevant areas under the ROC curve greater than 0.700 for the prediction of mortality after liver transplantation. All calculated Brier scores were greater than 0.25, indicating a significant lack of model discrimination and calibration of the investigated scores. CONCLUSIONS A prognostic model for the prediction of outcome after transplantation still needs to be identified and should allow weighing urgency against utility in liver transplantation.